Skip to main content
. 2022 Jun 21;17(1):e12–e21. doi: 10.1055/s-0042-1748535

Fig. 2.

Fig. 2

Subcutaneous osmotic pump delivery system utilized for recombinant follistatin protein and sham protein treatment groups.